Cargando…

Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients

BACKGROUND: No clear guidelines or available studies exist regarding the effects of intensity-modulated radiotherapy (IMRT) of esophageal cancer (EC) on the cardiovascular system. We therefore analyzed a wide range of cardiac vascular dosimetric parameters and clinical characteristics to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiandong, Lv, Yajuan, Chen, Fangjie, Wang, Xiaotong, Zhang, Li, Zhang, Xiaozhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867929/
https://www.ncbi.nlm.nih.gov/pubmed/33569468
http://dx.doi.org/10.21037/atm-21-184
_version_ 1783648376219238400
author Zhang, Jiandong
Lv, Yajuan
Chen, Fangjie
Wang, Xiaotong
Zhang, Li
Zhang, Xiaozhi
author_facet Zhang, Jiandong
Lv, Yajuan
Chen, Fangjie
Wang, Xiaotong
Zhang, Li
Zhang, Xiaozhi
author_sort Zhang, Jiandong
collection PubMed
description BACKGROUND: No clear guidelines or available studies exist regarding the effects of intensity-modulated radiotherapy (IMRT) of esophageal cancer (EC) on the cardiovascular system. We therefore analyzed a wide range of cardiac vascular dosimetric parameters and clinical characteristics to assess the prognostic factors for EC patients treated with IMRT. METHODS: A total of 112 patients receiving IMRT at the Qianfoshan Hospital between July 2012 and May 2017 were retrospectively reviewed. The dose per fraction was 1.8–2.0 Gy, and the total dose range was 54–66 Gy. Kaplan-Meier analysis was used to estimate death due to heart disease. Univariate and multivariate logistic regression models were calculated to test for associations between patient characteristics and dose-volume histogram (DVH) parameters. A t-test and chi-squared or Fisher’s exact test was used to analyze the comparisons. RESULTS: The maximum and mean doses received by the heart were 57.34±13.51 and 24.83±11.40 Gy, respectively. Among the parameters examined, which included the maximum dose received by the heart, the mean dose received by the right and left ventricle (RV and LV), and the maximum dose received by the right atrium (RA), the mean dose received by the RV predicted survival and was included in our multivariate analysis. The results indicated that patients with basic heart disease who were undergoing concurrent radiochemotherapy were more likely to have cardiac disease. CONCLUSIONS: This is first study to examine the prognosis of cardiovascular vessels exposed to various radiation doses during the treatment of EC, the findings of which suggest that limiting radiation exposure may be an important measure in IMRT application. These findings of this study may provide theoretical support for prediction of radiation-induced heart disease (RIHD). Furthermore, to curb the risk of RIHD, the modality of chemotherapy also needs to be attentively monitored and managed.
format Online
Article
Text
id pubmed-7867929
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-78679292021-02-09 Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients Zhang, Jiandong Lv, Yajuan Chen, Fangjie Wang, Xiaotong Zhang, Li Zhang, Xiaozhi Ann Transl Med Original Article BACKGROUND: No clear guidelines or available studies exist regarding the effects of intensity-modulated radiotherapy (IMRT) of esophageal cancer (EC) on the cardiovascular system. We therefore analyzed a wide range of cardiac vascular dosimetric parameters and clinical characteristics to assess the prognostic factors for EC patients treated with IMRT. METHODS: A total of 112 patients receiving IMRT at the Qianfoshan Hospital between July 2012 and May 2017 were retrospectively reviewed. The dose per fraction was 1.8–2.0 Gy, and the total dose range was 54–66 Gy. Kaplan-Meier analysis was used to estimate death due to heart disease. Univariate and multivariate logistic regression models were calculated to test for associations between patient characteristics and dose-volume histogram (DVH) parameters. A t-test and chi-squared or Fisher’s exact test was used to analyze the comparisons. RESULTS: The maximum and mean doses received by the heart were 57.34±13.51 and 24.83±11.40 Gy, respectively. Among the parameters examined, which included the maximum dose received by the heart, the mean dose received by the right and left ventricle (RV and LV), and the maximum dose received by the right atrium (RA), the mean dose received by the RV predicted survival and was included in our multivariate analysis. The results indicated that patients with basic heart disease who were undergoing concurrent radiochemotherapy were more likely to have cardiac disease. CONCLUSIONS: This is first study to examine the prognosis of cardiovascular vessels exposed to various radiation doses during the treatment of EC, the findings of which suggest that limiting radiation exposure may be an important measure in IMRT application. These findings of this study may provide theoretical support for prediction of radiation-induced heart disease (RIHD). Furthermore, to curb the risk of RIHD, the modality of chemotherapy also needs to be attentively monitored and managed. AME Publishing Company 2021-01 /pmc/articles/PMC7867929/ /pubmed/33569468 http://dx.doi.org/10.21037/atm-21-184 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zhang, Jiandong
Lv, Yajuan
Chen, Fangjie
Wang, Xiaotong
Zhang, Li
Zhang, Xiaozhi
Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
title Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
title_full Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
title_fullStr Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
title_full_unstemmed Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
title_short Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
title_sort doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867929/
https://www.ncbi.nlm.nih.gov/pubmed/33569468
http://dx.doi.org/10.21037/atm-21-184
work_keys_str_mv AT zhangjiandong dosesofintensitymodulatedradiotherapyanditsassociationwithcardiacdiseaseinesophagealcancerpatients
AT lvyajuan dosesofintensitymodulatedradiotherapyanditsassociationwithcardiacdiseaseinesophagealcancerpatients
AT chenfangjie dosesofintensitymodulatedradiotherapyanditsassociationwithcardiacdiseaseinesophagealcancerpatients
AT wangxiaotong dosesofintensitymodulatedradiotherapyanditsassociationwithcardiacdiseaseinesophagealcancerpatients
AT zhangli dosesofintensitymodulatedradiotherapyanditsassociationwithcardiacdiseaseinesophagealcancerpatients
AT zhangxiaozhi dosesofintensitymodulatedradiotherapyanditsassociationwithcardiacdiseaseinesophagealcancerpatients